Business
TLX66 in Phase II Academic Study of Pediatric Leukemia
TLX66 in Phase II Academic Study of Pediatric Leukemia
About this update from Telix Pharmaceuticals Limited
[{"type":"text","content":"Telix Pharmaceuticals Ltd has released a press release. View Attachment","length":249,"tagName":"div"}]